{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:46:00Z","timestamp":1761597960491,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004689","name":"Consejo de Desarrollo Cient\u00c3\u00adfico, Human\u00c3\u00adstico y Tecnol\u00c3\u00b3gico, Universidad del Zulia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009943","name":"Universidad Central de Venezuela","doi-asserted-by":"publisher","award":["PG PG-03-8289-2011\/1"],"award-info":[{"award-number":["PG PG-03-8289-2011\/1"]}],"id":[{"id":"10.13039\/501100009943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijantimicag.2018.06.016","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T08:35:35Z","timestamp":1530347735000},"page":"682-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B"],"prefix":"10.1016","volume":"52","author":[{"given":"Elizabeth","family":"Valdivieso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0001","unstructured":"WHO, 2010. Control of the Leishmaniasis. Report of a Meeting of the WHO, Expert Committee on the Control of Leishmaniasis. WHO Technical Report. Series 949. World Health Organization, Geneva, Switzerland."},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0002","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"Van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0004","first-page":"357","article-title":"Leishmania\/HIV coinfections in the second decade","volume":"123","author":"Cruz","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0005","first-page":"251","article-title":"HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-coinfected individuals","volume":"13","author":"Van Griensven","year":"2013","journal-title":"J Infec Dis"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0006","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"Trudel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0007","doi-asserted-by":"crossref","first-page":"e4918","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"Santos","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0008","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.exppara.2010.06.002","article-title":"Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp","volume":"126","author":"Valdivieso","year":"2010","journal-title":"Ex Parasitol"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.10-178947","article-title":"HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites","volume":"25","author":"White","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12192-012-0368-9","article-title":"Ddi1-like protein from Leishmania major is an active aspartyl proteinase","volume":"18","author":"Perteguer","year":"2012","journal-title":"Cell Stress Chap"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0012","first-page":"2869","article-title":"Visceral leishmaniasis and HIV coinfection in East Africa","volume":"8","author":"Diro","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0013","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/ijbs.9224","article-title":"Recent advances in drug repositioning for the discovery of new anticancer drugs","volume":"10","author":"Shin","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0014","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.22.5.743","article-title":"Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method","volume":"22","author":"Hallander","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1756-3305-6-122","article-title":"Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV\u2212 patients in the murine model of visceral leishmaniasis","volume":"6","author":"Cunha","year":"2013","journal-title":"Parasit Vectors"},{"issue":"11","key":"10.1016\/j.ijantimicag.2018.06.016_bib0017","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity","volume":"42","author":"Mary","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0018","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","article-title":"In vitro interactions between simaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani","volume":"66","author":"Seifert","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkt318","article-title":"In vitro interaction between paramomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species","volume":"69","author":"Morais-Teixeira","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0020","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/AAC.00505-09","article-title":"Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis","volume":"53","author":"Serrano-Mart\u00edn","year":"2009","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0022","doi-asserted-by":"crossref","first-page":"18050","DOI":"10.1038\/s41598-017-18374-y","article-title":"Resequencing of the Leishmania infantum (strain JPCM5) genome and de novo assembly into 36 contigs","volume":"7","author":"Gonz\u00e1lez-de la Fuente","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.06.016_bib0023","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:10Z","timestamp":1760376730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918301845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0924857918301845"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.06.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}